Atinvicitinib
Product Specifications
CAS Number
2169273-59-8
Target
JAK
Related Pathways
JAK/STAT signaling|||Chromatin/Epigenetic|||Tyrosine Kinase/Adaptors|||Angiogenesis|||Stem Cells
Purity
0.9936
Bioactivity
Atinvicitinib, a selective Janus kinase (JAK) inhibitor, demonstrates high specificity for Janus kinase 1 (JAK1), consequently inhibiting downstream cytokine signaling pathways that rely on JAK1 enzymatic activity. Atinvicitinib modulates a wide range of cytokines that are implicated in itch responses, allergic reactions, and inflammatory conditions, making it a significant research tool for studying cytokine-mediated immune processes as well as therapeutic modulation of allergic and inflammatory diseases.
Smiles
COc1cc(Nc2nn(cc2C(N)=O)[C@H]2COCC[C@@H]2C#N)cc(F)n1
Molecular Formula
C16H17FN6O3
Molecular Weight
360.35
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
I7661-39AX-APC 100 µL
Integrin, beta1 (CD29, Very Late Antigen, VLAb1, Platelet gplla) (BSA & Azide Free) (APC) discontinued
Ask
View Details 
MBS6367425-02 5x 0.1 mL
ZNF678, CT (ZNF678, Zinc finger protein 678) (MaxLight 750)
Ask
View Details 
P5750-80B 100 µg
PRDM16 (PR Domain Zinc Finger Protein 16, PR Domain-containing Protein 16, Transcription Factor MEL1, MDS1/EVI1-like Gene 1, KIAA1675, MEL1, PFM13)
Ask
View Details 